药物遗传学对对眼睛低压剂的个体反应的影响 青光眼患者
Sara Labay-Tejado1, Virginia Fortuna2, Néstor Ventura-Abreu3
1Department of Ophthalmology (ICOF), Hospital Clínic de Barcelona, Universitat de Barcelona, Carrer de Sabino Arana 1, 08028 Barcelona, Spain.
Pharmaceutics
|March 27, 2025
概括
遗传变异会影响青光眼和眼睛高血压患者对降眼压治疗的反应. 了解这些遗传标记,如PTGFR和ADRB2,可以帮助定制治疗以获得更好的结果.
科学领域:
- 眼科医生 眼科 眼科
- 药物遗传学 药物遗传学
- 遗传学 遗传学 是一个
背景情况:
- 玻璃眼和眼睛高血压 (OHT) 管理需要了解个体患者对眼睛低血压治疗的反应.
- 基因型-表型相关性可以预测治疗疗效,并指导个性化医疗方法.
研究的目的:
- 调查特定基因多态性和患有绿眼病或OHT的患者的表型特征之间的关系.
- 探索这些基因型如何影响对眼部低血压单一治疗的反应.
主要方法:
- 对109名患有青光眼或OHT的患者 (193只眼睛) 进行前性研究,这些患者服用β-阻断剂 (BB),前列腺素类似物 (PGAs) 或前列腺胺类类似物 (PDs).
- 在PTGFR,ADRB2和CYP2D6中使用实时PCR的八种单核酸多态的基因定型.
- 评估眼内压力 (IOP) 变化 (vIOP),治疗IOP (tIOP),基线IOP (bIOP) 和视野的平均偏差 (MD).
主要成果:
- 在PGA组中发现PTGFR (rs3753380) 和vIOP之间的显著关联 (p=0.032).
- ADRB2 (rs1042714) 在MD (p<0.001) 和vIOP (p=0.017) 中显示出显著的差异.
- 在BBs上的CYP2D6超快代谢剂具有较高的tIOP (p=0.010) 和较低的vIOP (p=0.046);由CYP2D6代谢的全身治疗影响了vIOP (p=0.019).
结论:
- 初步发现表明,药物遗传学可以预测青光眼和OHT的治疗反应.
- 基因型定制可能使个性化治疗策略成为最佳的眼睛低血压条件的临床管理.
相关概念视频
Open Angle Glaucoma: Treatment
375
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
375
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
35
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
35
Glaucoma: Overview
484
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
484
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
882
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
882
Factors Affecting Drug Response: Overview
1.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.1K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.1K


